Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» HIV
HIV
Antiretroviral Therapy's Positive Impact On Global Public Health Faces Challenges Moving Forward
Forbes
Mon, 08/12/19 - 10:28 am
HIV
Public Health
antiretrovirals
Roche Expands Global Access to Viral Assays to Aid Eradication Efforts
Medical Devices and Diagnostics Industry
Fri, 08/9/19 - 07:42 pm
Roche
viral assays
HIV
HPV
diagnostics
Global Access Program
FDA AdCom backs Gilead's move to expand Descovy label — but stops short of endorsing broad PrEP use
Endpoints
Thu, 08/8/19 - 12:56 pm
FDA
Gilead Sciences
HIV
Descovy
PrEP
Regulators, Gilead at odds over HIV drug's use in women
Biopharma Dive
Mon, 08/5/19 - 10:31 pm
Gilead Sciences
HIV
Descovy
ViiV’s first-in-class HIV drug on course for filings this year
Pharmaforum
Tue, 07/23/19 - 10:16 am
ViiV Healthcare
HIV
fostemsavir
FDA
Busy Gilead crew throws struggling biotech a lifeline, with some cash upfront and hundreds of millions in biobucks for HIV deal
Endpoints
Mon, 07/22/19 - 10:08 am
Gilead Sciences
Durect
HIV
hepatitis B
extended release
J&J gears up for clinical test of HIV vaccine efficacy
Fierce Biotech
Mon, 07/15/19 - 10:06 am
JNJ
clinical trials
HIV
vaccines
Pharma Stock Roundup: Pipeline & Regulatory Updates by MRK, GSK, SNY
Yahoo/Zacks.com
Sat, 07/13/19 - 11:34 am
GSK
HIV
FDA
Merck
Keytruda
Sanofi
isatuximab
Roche
JNJ
Scripps Research Snags $129 Million for HIV Vaccine Investigation
BioSpace
Thu, 07/11/19 - 11:01 pm
Scripps Research Institute
HIV
vaccines
ViiV's HIV Drug Hits Endpoints in Late-Stage Comparison Trial
BioSpace
Wed, 07/10/19 - 10:18 am
GSK
ViiV Healthcare
Dovato
HIV
Gilead and Lyndra Team Up to Develop Long-Acting HIV Therapies
BioSpace
Tue, 07/9/19 - 06:44 pm
Gilead Sciences
Lyndra Therapeutics
HIV
ViiV Healthcare begins study on implementation of once-monthly injectable HIV treatment
Pharmaceutical Business Review
Tue, 07/9/19 - 08:51 am
ViiV Healthcare
HIV
cabotegravir
rilpivirine
Using CRISPR to eliminate HIV
Fierce Biotech
Wed, 07/3/19 - 10:35 am
HIV
CRISPR
FDA Eliminates REMS for HIV Drug Truvada and its Generics
RAPS.org
Tue, 07/2/19 - 12:06 pm
FDA
Gilead Sciences
Truvada
HIV
REMS
U.S. Reps to Gilead: Did your donation of free HIV prevention drug Truvada have strings attached?
Fierce Pharma
Thu, 06/27/19 - 11:43 am
Gilead Sciences
Truvada
HIV
patents
Influential task force urges payers to cover PrEP for HIV
Healthcare Dive
Wed, 06/12/19 - 06:42 pm
HIV
PrEP
Gilead Sciences
Truvada
Affordable Care Act
US Preventive Services Task Force
Daily HIV prevention pill urged for healthy people at risk
Stat
Tue, 06/11/19 - 06:03 pm
HIV
PrEP
Truvada
Gilead Sciences
J&J passes key milestone in HIV vaccine trial
Pharmaforum
Thu, 05/30/19 - 09:40 am
JNJ
Janssen
clinical trials
vaccines
HIV
Imbokodo
Medicare decides against tighter management of HIV drugs
Biopharma Dive
Fri, 05/17/19 - 01:05 pm
HHS
Medicare
HIV
Medicare Part D
Gilead defends Truvada pricing during House hearing
BioCentury
Thu, 05/16/19 - 11:26 pm
Gilead Sciences
Truvada
HIV
drug pricing
US Congress
Pages
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
…
next ›
last »